ABUS Stock: Arbutus Biopharma Corporation Stock Price, Analysis & Insights
Get live ABUS stock price $4.13, comprehensive Arbutus Biopharma Corporation stock analysis, charts, news, and expert forecast. Real-time ABUS stock data and investment insights.
Loading chart data...
Arbutus Biopharma Corporation (ABUS) Overview
Arbutus Biopharma Corporation (ABUS) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, ABUS trades at $4.13 with a market capitalization of 815.83M . Over the past 52 weeks, ABUS has traded between $3.04 and $5.10 , with the current price positioned at approximately 53% of this range . The stock currently t...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 815.83M
- Current price: $4.13
- 52-week range: $3.04 - $5.10
- P/E ratio: 4.98
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Arbutus Biopharma Corporation, a biopharmaceutical company operating in the United States, focuses on the discovery and development of novel therapies for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. Central to its ...
Company Information
- CEO
- Lindsay Androski
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 44
Contact Information
- Website
- https://www.arbutusbio.com
- Address
- 701 Veterans Circle
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 5.0)
✓ Lower volatility stock (Beta: 0.63) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Arbutus Biopharma Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Arbutus Biopharma Corporation
- ⚠Investors should consider how Arbutus Biopharma Corporation fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
815.83M
P/E Ratio (TTM)
4.98
Beta
0.63
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.